Is Cash King? A Case Study for European Insurers looking to reduce Regulatory Capital
By Shadrack Kwasa | 21 Sep, 2020
Since the COVID-19 crisis escalated in early 2020, we have spoken with a number of insurers looking to reduce their regulatory capital requirement as a way to navigate a possible economic recession. For many of these insurers, common sense leads them to considering larger allocations to cash in their portfolios as an obvious way to reduce investment risk and minimise the use of regulatory capital.
However, despite the obvious logic, increasing your allocation to cash does not always deliver the expected outcome. Although cash is a “safe” asset from an investment perspective, it comes with counter-party risk from a regulatory perspective (i.e. risk that the institution holding the cash goes bust). As such, the regulatory capital charges associated with holding cash completely depends on how you are holding that cash and the counterparty risk of the institution where the cash is held.
Read the whole piece here
To speak to the Institutional Team, please give us a call on +44 (0) 207 396 3388, alternatively email insurance@londonandcapital.com or get in contact here.
Disclaimer: The value of investments and any income from them can fall as well as rise and neither is guaranteed. Investors may not get back the capital they invested. Past performance is not indicative of future performance. The material is provided for informational purposes only. No news or research item is a personal recommendation to trade. Nothing contained herein constitutes investment, legal, tax or other advice.
Copyright © London and Capital Asset Management Limited. London and Capital Asset Management Limited is authorised and regulated by the Financial Conduct Authority of 12 Endeavour Square, London E20 1JN, with firm reference number 143286. Registered in England and Wales, Company Number 02112588. London and Capital Wealth Advisers Limited is authorised and regulated by both by the Financial Conduct Authority of 12 Endeavour Square, London E20 1JN, with firm reference number 120776 and the U.S. Securities and Exchange Commission of 100 F Street, NE Washington, DC 20549, with firm reference number 801-63787. Registered in England and Wales, Company Number 02080604
